FDA expected to approve Johnson & Johnson COVID-19 vaccine

  • By cvbizz
  • February 25, 2021
  • 0
  • 91 Views
Share This Post!

Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19, and about 85% effective against the most serious illness. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days.

The vaccination drive has been slower than hoped, hampered by logistical issues and weather delays even as the country mourns more than 500,000 virus-related deaths. So far, about 44.5 million Americans have received at least one dose of vaccine made by Pfizer or Moderna, and nearly 20 million of them have received the second dose required for full protection. #WakeUpCLT #Vaccine #COVID19

FULL STORY: https://www.wcnc.com/article/news/health/coronavirus/vaccine/johnson-johnson-single-dose-covid-19-vaccine/507-74d741fb-d4fb-4c5d-8271-e24d1cd8e025

PHP Code Snippets Powered By : XYZScripts.com
X